Search - tctmd.com

Displaying 1 - 20 of 191

Sort: Relevancy | Date

News Daily News

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Michael O'Riordan

January 26, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Todd Neale

September 01, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Conference News ESC 2024

Complete Revascularization Better for Older STEMI Patients: Meta-analysis

Todd Neale

September 04, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Daily News

Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery

Michael O'Riordan

July 11, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

Advertisement

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Frail Patients Stand to Gain Most From Cardiac Rehab

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Top Coronary Artery Disease News in 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Complete Revascularization Better for Older STEMI Patients: Meta-analysis

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content